Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04125940 · ClinicalTrials.gov registry record · NA
Blood Nitrate/Nitrite Concentrations Following Acute Ingestion of Resync in Men and Women
A NA study, sponsored by University of Memphis.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT04125940: Completed NA study, sponsored by University of Memphis.
NCT04125940 is a NA study that has completed, run by University of Memphis. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04125940, a NA study, has completed, sponsored by University of Memphis.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This study evaluates acute ingestion of the dietary supplement Resync on blood nitrate/nitrite concentrations in a sample of men and women. This will be a crossover trial in which participants take all 4 conditions: 1) 7.5g Resync, 2) 15g Resync, 3) 20g Resync+collagen, 4) placebo.
Primary Outcome
We will determine the change in daily blood nitrate+nitrite from the daily baseline blood nitrate+nitrite with 1 serving (7.5g) of Resync. Resync powder will be mixed with 12oz of water.
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Resync
- DIETARY_SUPPLEMENT Resync + Collagen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2019-10-14 |
| Est. Completion | 2019-12-30 |
| Phase | NA |
What the finished NCT04125940 record still lists
NCT04125940 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT04125940 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04125940 about?
NCT04125940 is a clinical study titled "Blood Nitrate/Nitrite Concentrations Following Acute Ingestion of Resync in Men and Women". This study evaluates acute ingestion of the dietary supplement Resync on blood nitrate/nitrite concentrations in a sample of men and women. This will be a crossover trial in which participants take all 4 conditions: 1) 7.5g Resync, 2) 15g Resync, 3) 20g Resync+collagen, 4) placebo.
What is the current status of trial NCT04125940?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2019-10-14. Estimated completion is 2019-12-30.
What interventions are being tested in trial NCT04125940?
The interventions under investigation include: Placebo (OTHER), Resync (DIETARY_SUPPLEMENT), Resync + Collagen (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04125940?
This trial is sponsored by University of Memphis, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04125940's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI